Related Experiment Video
Updated: Apr 6, 2026
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
Aortic stenting
Ionel Droc1, Francisca Blanca Calinescu2, Gabriela Droc3
1a 1 Cardiovascular Surgery Department, Army's Center for Cardio-vascular Diseases , Bucharest, Romania.
Insights
Endovascular repair is increasingly used for aortic pathologies. This study reports successful outcomes for endovascular abdominal aortic repair (EVAR), highlighting its potential as a gold standard treatment.
Area of Science:
- Vascular Surgery
- Endovascular Interventions
- Aortic Pathology
Background:
- Endovascular approaches are becoming standard for thoracic and abdominal aortic pathologies.
- Thoracic endovascular repair (TEVAR) is widely accepted for descending thoracic aorta diseases.
- Indications for TEVAR are expanding to include aortic arch and ascending aorta conditions.
Purpose of the Study:
- To report the outcomes of elective endovascular abdominal aortic repair (EVAR) in a multi-center setting.
- To evaluate the efficacy and safety of various endograft devices in EVAR procedures.
- To assess the current status and future potential of EVAR for abdominal aortic aneurysms.
Main Methods:
- Retrospective analysis of 55 elective EVAR cases from two vascular surgical centers.
- Utilized various endoprostheses including E-vita Abdominal XT, Excluder, Talent, PowerLink, Endurant, and custom-made devices.
- Follow-up included CT scans, duplex ultrasound, and contrast-enhanced ultrasound over a mean period of 18 months.
Main Results:
- A low mortality rate of 2% was observed in the 55 elective EVAR cases.
- Mean follow-up of 18 months demonstrated the feasibility and safety of the procedures.
- A variety of endograft devices were used, indicating adaptability to different patient anatomies.
Conclusions:
- EVAR is a highly effective treatment for abdominal aortic aneurysms, with potential to become the gold standard.
- Technological advancements in endograft devices, particularly lower profile systems, will broaden anatomical indications.
- Continued evolution of endovascular techniques promises improved outcomes and expanded applications in aortic disease management.
Abstract:
The approach to aortic pathology is nowadays more and more endovascular at both thoracic and abdominal levels. Thoracic stenting has gained worldwide acceptance as first intention to treat pathologies of the descending thoracic aorta. Indications have been extended to aortic arch aneurysms and also to diseases of the ascending aorta. The current devices in use for thoracic endovascular repair (TEVAR) are Medtronic Valiant, Gore TAG, Cook Tx2 and Jotec. The choice of the endograft depends on the thoracic aortic pathology and the anatomical suitability. The technological evolution of the abdominal aortic endografts was very rapid, arriving now at the fourth generation. We report the results of 55 elective cases of endovascular abdominal aortic repair (EVAR) performed in two vascular surgical centers in Romania and Germany. The prostheses used were 16 E-vita Abdominal XT, 12 Excluder, eight Talent, seven PowerLink, three Endurant and nine custom-made, fenestrated or branched from Jotec. The mean follow-up was 18 months with CT-scan, duplex ultrasound and contrast-enhanced ultrasound. The mortality was 2%. EVAR tends to become the gold standard for abdominal aortic aneurysm repair. Technological development of the devices with lowest profile introduction systems will permit to extend the anatomical indications to new frontiers.
More Related Videos
06:51Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
Published on: October 20, 2023
11:07Biodegradable Magnesium Stent Treatment of Saccular Aneurysms in a Rat Model - Introduction of the Surgical Technique
Published on: October 1, 2017
